| HealthPartners | Oncology - luspatercept-aamt (Reblozyl®) – Minnesota | 2025-04-01 |
| HealthPartners | Oncology** - immune globulin therapy – Minnesota | 2025-04-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Assisted Reproductive Technology | 2025-04-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Dynamic Splinting Devices | 2025-04-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Denileukin diftitox-cxdl (Lymphir) | 2025-04-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Bortezomib (Velcade) | 2025-04-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Testosterone Androgens | 2025-04-01 |
| BCBS Highmark Penn Medicare Advantage | Implantable Continuous Glucose Monitors | 2025-04-01 |
| BCBS Highmark Penn Medicare Advantage | Denileukin diftitox-cxdl (Lymphir) | 2025-04-01 |
| BCBS Highmark Penn Medicare Advantage | Bortezomib (Velcade) | 2025-04-01 |